Close
Open
Share on Facebook
Twitter
Google+
Email
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

COVID-19 Updates:      COVID-19 Resources »      Vaccine Update »      Updated Visitor Policy »      What We're Doing to Keep You Safe »

Menu
Search
Menu
Search
  • Doctors, Clinics & Locations, Conditions & Treatments
  • Patients & Visitors
  • MyHealth
  • Billing
  • Insurance
  • Medical Records
  • Support Groups
  • Financial Assistance
  • COVID-19 Resource Center
  • Locations and Parking
  • Visitor Policy
  • Hospital Check-in
  • International Patients
  • Contact Us
View All Information for Patients & Visitors »
We are available to assist you 24/7.
650-498-3333
GuestServices@stanfordhealthcare.org


View the changes to our visitor policy »

 

View information for Guest Services »

New to MyHealth?

Manage Your Care From Anywhere.

Access your health information from any device with MyHealth.  You can message your clinic, view lab results, schedule an appointment, and pay your bill.

ALREADY HAVE AN ACCESS CODE?

Activate Account

DON'T HAVE AN ACCESS CODE?

Create a New Account

NEED MORE DETAILS?

Learn More about MyHealth »

MyHealth for Mobile

Get the iPhone MyHealth app »
Get the Android MyHealth app »

WELCOME BACK

Forgot Username or Password?
Need Help?

Clear

What to Expect - Pulmonary Metastasectomy

  • About
  • About
Overview
Conditions Treated
What To Expect
Overview
Conditions Treated
What To Expect

What To Expect from a Pulmonary Metastasectomy

The rationale of lung resection

Patients with untreated metastatic disease have a 5-year survival rate of less than 5-10% on average. For a patient with isolated metastatic disease to the lungs (i.e., with no metastases to other parts of the body), pulmonary metastasectomy (surgical removal of the lung tumors) is the best hope for cure. Numerous studies have demonstrated 5-year survival rates of 30 to 50% for a variety of primary tumors when they spread to the lungs but then are surgically removed. These survival rates are far superior to any other treatment currently available. Regardless of the primary tumor, completeness of resection is the key to achieving long-term survival/cure. Since these operations can be performed with very low morbidity and mortality rates, and offer a chance for cure in otherwise incurable patients, surgery is very often recommended.

Number of tumors

The number of tumors found in the lung is a factor when determining whether or not to undergo surgery. In general, the presence of fewer, or solitary, tumors occurring at a remote time from the primary cancer diagnosis will factor favorably into the decision to offer a lung operation. However, the presence of multiple metastatic tumors does not preclude lung resection, and even if the metastases are present at the time of (synchronous with) identification of the primary tumor, resection can be considered.

Our group favors a relatively aggressive approach, and we do not consider the number of metastases per se to be limiting. What is more important is the feasibility of resecting all sites of disease in the context of leaving adequate lung function in reserve.

Use of minimally invasive techniques

The newest surgical approach to pulmonary metastasectomy is by video-assisted thoracoscopic surgery (VATS). This minimally invasive approach provides excellent exposure of the lung surface, and by palpation nodules below the surface. It reduces surgical trauma, minimizes postoperative pain, provides earlier patient mobilization, and decreases hospital length of stay. Pulmonary metastases are often small nodules located in the periphery of the lung, well suited for wedge resection by stapler and the VATS approach when they are limited in number (generally 3 or less). In case of recurrence of pulmonary disease, and if the patient fulfils the initial criteria for pulmonary metastasectomy, repeat surgery can be performed.

When more nodules are present, or more complex resections are required, thoracotomy may be recommended. This allows the surgeon to carry out bimanual palpation of the entire lung, and it likely reduces the chance of tiny, more difficult-to-find nodules being missed. This comes at the cost, however, of greater patient discomfort and greater difficulty if later reoperation is required.

Previous Section Next Section

INTERESTED IN AN ONLINE SECOND OPINION?

The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!

Visit our online second opinion page to learn more.

Other Clinics

  • Pleasanton
    925-263-5747
  • Thoracic Surgery Clinic
    650-498-6000
  • Find a Doctor
  • Find Conditions & Treatments
  • Find a Stanford clinic
  • For Patients & Visitors
  • Billing
  • Insurance
  • Hospital Check-in
  • Contact Us
  • Get a Second Opinion
  • COVID-19 Resource Center
  • Make a Gift
  • About Us
  • Quality & Safety
  • Annual Report
  • Stanford Health Care Now
  • For Healthcare Professionals
  • Referring Physicians
  • Nursing
  • Allied Healthcare Professionals
First Responders
  • Newsroom
  • Careers
  • Volunteering
  • Vendors
  • University HealthCare Alliance
  • Stanford Health Care – ValleyCare
  • Stanford Medicine
  • Stanford Children's Health
  • Stanford University
  • Legal
  • Privacy
  • Code of Conduct
  • |   Notice of Nondiscrimination     ©2020 Stanford Health Care. All Rights Reserved
Home
Close
Doctors
Clinics & Locations
Conditions & Treatments
Clinical Trials
MyHealth Login

Patients & Visitors
Billing
Insurance
Financial Assistance
Medical Records
Contact Us
Get a Second Opinion
COVID-19 Resource Center
Healthcare Professionals
Referring Physicians
Nursing
Allied Healthcare
About Us
Quality & Safety
Careers
Newsroom
Make a Donation
Stanford Health Care Now
Close